Quint A. J. Hagdorn

Cellular senescence impairs the reversibility of pulmonary arterial hypertension

Diederik E. van der Feen, Guido P. L. Bossers, Quint A. J. Hagdorn et al. · Science Translational Medicine · 2020 · 141 citations · Full text

Education, Cardiology, Physiology +14

A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing

Quint A. J. Hagdorn, Guido P. L. Bossers, Anne‐Marie C. Koop et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2019 · 51 citations · Full text

Life Sciences, Animal Sciences, Physiology +16

Risk of cardiac tachyarrhythmia in patients with repaired tetralogy of Fallot: a multicenter cardiac MRI based study

Niek E. G. Beurskens, Quint A. J. Hagdorn, Thomas M. Gorter et al. · International journal of cardiac imaging · 2018 · 32 citations · Full text

Medicine, Cardiology, Radiology +16

CMR feature tracking left ventricular strain-rate predicts ventricular tachyarrhythmia, but not deterioration of ventricular function in patients with repaired tetralogy of Fallot

Quint A. J. Hagdorn, Johan D.L. Vos, Niek E. G. Beurskens et al. · International Journal of Cardiology · 2019 · 30 citations · Full text

Medicine, Cardiology, Radiology +17

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation

Emmanouil Mavrogiannis, Quint A. J. Hagdorn, Venetia Bazioti et al. · Pulmonary Circulation · 2022 · 24 citations · Full text

Veterinary Medicine, Cardiology, Pharmacology +17